Immune cell labelling and tracking: implications for adoptive cell transfer therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2365-421X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immune cell labelling and tracking: implications for adoptive cell transfer therapies ; volume:6 ; number:1 ; day:3 ; month:2 ; year:2021 ; pages:1-19 ; date:12.2021
EJNMMI radiopharmacy and chemistry ; 6, Heft 1 (3.2.2021), 1-19, 12.2021
- Urheber
-
Galli, Filippo
Varani, Michela
Lauri, Chiara
Silveri, Guido Gentiloni
Onofrio, Livia
Signore, Alberto
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s41181-020-00116-7
- URN
-
urn:nbn:de:101:1-2021032711530220321551
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Galli, Filippo
- Varani, Michela
- Lauri, Chiara
- Silveri, Guido Gentiloni
- Onofrio, Livia
- Signore, Alberto
- SpringerLink (Online service)
Ähnliche Objekte (12)
CRISPR–Cas9 applications in T cells and adoptive T cell therapies
High-throughput screening for optimizing adoptive T cell therapies
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies
Adoptive cellular therapies: the current landscape
Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies
Non-viral nS/MAR DNA Vector-Based Genetic Modification of T Cells: Revolutionizing Adoptive Cell Therapies
Adoptive T-cell therapy for Leukemia
Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies
Adoptive cell transfer therapy for hepatocellular carcinoma
Improving adoptive T cell therapies of cancer by ectopic expression of miR181a to repress inhibitory phosphatases
Adoptive Cell Therapy from the Dish: Potentiating Induced Pluripotent Stem Cells
CRISPR–Cas9 applications in T cells and adoptive T cell therapies
High-throughput screening for optimizing adoptive T cell therapies
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies
Adoptive cellular therapies: the current landscape
Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies
Non-viral nS/MAR DNA Vector-Based Genetic Modification of T Cells: Revolutionizing Adoptive Cell Therapies
Adoptive T-cell therapy for Leukemia
Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies
Adoptive cell transfer therapy for hepatocellular carcinoma
Improving adoptive T cell therapies of cancer by ectopic expression of miR181a to repress inhibitory phosphatases
Adoptive Cell Therapy from the Dish: Potentiating Induced Pluripotent Stem Cells
CRISPR–Cas9 applications in T cells and adoptive T cell therapies
High-throughput screening for optimizing adoptive T cell therapies
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies
Adoptive cellular therapies: the current landscape
Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies
Non-viral nS/MAR DNA Vector-Based Genetic Modification of T Cells: Revolutionizing Adoptive Cell Therapies
Adoptive T-cell therapy for Leukemia
Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies
Adoptive cell transfer therapy for hepatocellular carcinoma
Improving adoptive T cell therapies of cancer by ectopic expression of miR181a to repress inhibitory phosphatases